Zdrowie i gospodarka · 10/06/2016
FDA Releases Guidance on Compounding with Bulk Drug Substances
The FDA has announced the availability of a guidance document outlining its interim policy on compounding with bulk drug substances, which will allow licensed pharmacists and physicians to use these substances to create human drug products while the agency develops a list of approved substances.